Neotack 50 mg/2 ml (IM/IV Injection)
2 ml ampoule: ৳ 10.00 (2 x 5: ৳ 100.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Square pharmaceuticals plc |
| Also available as |
Indications
- Treatment of active duodenal ulcer
- Benign gastric ulcer
- Ulcer associated with non-steroidal anti-inflammatory agent
- Post operative stress ulcer
- Zollinger-Ellison Syndrome
- Gastroesophageal reflux disease (GERD)
- Gastro-intestinal haemorrhage from stress ulcer in seriously ill patient
- Recurrent haemorrhage in patients with bleeding peptic ulcer
- Preventive use before general anesthesia
- Treatment of episodic dyspepsia
Pharmacology
Competitively blocks histamine at H2-receptors, inhibits gastric acid secretion
Dosage & Administration
- Dosage for duodenal and gastric ulcer
- Dosage for reflux oesophagitis
- Dosage for Zollinger Ellison syndrome
- Dosage for episodic dyspepsia
- Maintenance dosage
- Recommended oral dose for children
Interaction
- Delayed absorption with propantheline bromide
- Minimally inhibits hepatic metabolism of certain drugs
- Alters absorption of pH-dependent drugs
- Reduces bioavailability with antacids
Contraindications
Hypersensitivity to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy & Lactation
- Ranitidine crosses the placenta
- Excreted in human breast milk
- Caution during nursing
Precautions & Warnings
Reduced dosage for impaired renal and hepatic function
Use in Special Populations
Use in elderly patients
Overdose Effects
No particular problems expected, symptomatic and supportive therapy
Therapeutic Class
H2 receptor antagonist
Reconstitution
- Reconstitution for slow IV injection
- Reconstitution for intermittent slow IV infusion
- Continuous IV infusion
- Special reconstitution for Zollinger-Ellison syndrome
Storage Conditions
Store in a cool and dry place, protect from light